Venus Concept Inc. (VERO)
Stock Price:
$2.54 USD
0.01 (0.40%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
102.44M |
| Revenue (ttm) |
133.59M |
| Net Income (ttm) |
-88.63M |
| Shares Out |
40.33M |
| EPS (ttm) |
-1.20 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 23, 2020 |
| Last Price |
$2.54 |
| Previous Close |
$2.53 |
| Change ($) |
0.01 |
| Change (%) |
0.40% |
| Day's Open |
2.55 |
| Day's Range |
2.48 - 2.67 |
| Day's Volume |
34,146 |
| 52-Week Range |
2.02 - 9.00 |
More Stats
| Market Cap |
102.44M |
| Enterprise Value |
161.66M |
| Earnings Date (est) |
Nov 16, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
40.33M |
| Float |
13.49M |
| EPS (basic) |
-1.20 |
| EPS (diluted) |
-1.20 |
| FCF / Share |
-1.62 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
324,422 |
| Short Ratio |
1.74 |
| Short % of Float |
2.40% |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
0.77 |
| PB Ratio |
2.60 |
| Revenue |
133.59M |
| Operating Income |
-69.33M |
| Net Income |
-88.63M |
| Free Cash Flow |
-54.00M |
| Net Cash |
-59.22M |
| Net Cash / Share |
-1.47 |
| Gross Margin |
85.63% |
| Operating Margin |
-51.90% |
| Profit Margin |
-69.00% |
| FCF Margin |
-40.42% |
| ROA |
-15.50% |
| ROE |
-272.59% |
| ROIC |
-66.70% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (4)
| Buy |
3 |
| Overweight |
0 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$7.20*
(183.46% upside)
Low
6.60
Current: $2.54
High
8.00
Target: 7.20
*Average 12-month price target from 3 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|
| Revenue | 110 | 103 | 21.30 | 15.60 | 17.23 |
| Revenue Growth | 7.59% | 381.82% | 36.52% | -9.46% | - |
| Gross Profit | 76.65 | 79.36 | 9.15 | 5.17 | 4.72 |
| Operating Income | -30.28 | -3.37 | -17.28 | -18.93 | -20.53 |
| Net Income | -40.62 | -14.96 | -17.84 | -21.85 | -22.97 |
| Shares Outstanding | 8.52 | 4.73 | 0.49 | 0.11 | 0.10 |
| Earnings Per Share | -4.77 | -3.16 | -36.30 | -203.09 | -220.49 |
| Operating Cash Flow | -39.60 | -33.65 | -19.26 | -16.16 | -24.12 |
| Capital Expenditures | -1.03 | -1.16 | -0.23 | -1.17 | -0.46 |
| Free Cash Flow | -40.62 | -34.80 | -19.49 | -17.34 | -24.57 |
| Cash & Equivalents | 15.75 | 6.76 | 23.65 | 11.91 | 17.13 |
| Total Debt | 69.02 | 56.55 | 13.00 | 20.45 | 19.71 |
| Net Cash / Debt | -53.27 | -49.79 | 10.64 | -8.54 | -2.59 |
| Assets | 191 | 125 | 32.97 | 19.50 | 26.48 |
| Liabilities | 114 | 88.68 | 19.78 | 27.31 | 25.02 |
| Book Value | 71.68 | 28.41 | 13.19 | -144 | -122 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Venus Concept Inc. |
| Country |
Canada |
| Employees |
525 |
| CEO |
Domenic Serafino |
Stock Information
| Ticker Symbol |
VERO |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: VERO |
Description
Venus Concept operates as a medical aesthetic technology company worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-treatment platform to address the aesthetic procedures without surgery or downtime; Venus Legacy, an advanced device that resolves challenging face and body aesthetic needs; Venus Velocity, a diode laser for hair removal; Venus Fiore, which addresses internal vaginal health restoration, labia skin tightening, and mons pubis reduction; Venus Viva, a customizable skin resurfacing device that allows operator control of ablation and coagulation for resolving the appearance of mild to severe skin damage for various skin types; Venus Freeze Plus, an anti-aging system for non-invasive skin tightening; and Venus Bliss, a solution for the fat reduction category. The company also offers NeoGraft, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process; and ARTAS and ARTAS iX robotic hair restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept Inc. is headquartered in Toronto, Canada.